Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical Trials Network

Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical Trials Network JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY Smith, P. K., Michler, R. E., Woo, Y. J., Alexander, J. H., Puskas, J. D., Parides, M. K., Hahn, R. T., Williams, J. B., Dent, J. M., Ferguson, T. B., Moquete, E., Rose, E. A., Page, P., Jeffries, N. O., O'Gara, P. T., Ascheim, D. D. 2012; 143 (1): 111-U175

Abstract

Patients with coronary artery disease complicated by moderate ischemic mitral regurgitation have demonstrably poorer outcome than do patients with coronary artery disease but without mitral regurgitation. The optimal treatment of this condition has become increasingly controversial, and a randomized trial evaluating current practices is warranted.We describe the design and initial execution of the Cardiothoracic Surgical Trials Network Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial.This is an ongoing prospective, multicenter, randomized, controlled clinical trial designed to test the safety and efficacy of mitral repair in addition to coronary artery bypass grafting in the treatment of moderate ischemic mitral regurgitation.The results of the Cardiothoracic Surgical Trials Network Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial will provide long-awaited information on controversial therapies for this morbid disease process.

View details for DOI 10.1016/j.jtcvs.2011.05.006

View details for Web of Science ID 000298151800018

View details for PubMedID 21788032